Cite
HARVARD Citation
Kawamura, T. et al. (2018). Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data. Cancer science. 109 (9), pp. 2822-2829. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kawamura, T. et al. (2018). Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data. Cancer science. 109 (9), pp. 2822-2829. [Online].